Filing Details

Accession Number:
0001209191-21-016859
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 16:25:41
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 16:25:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1288231 Phd P John Longenecker C/O Pacira Pharmaceuticals, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-01 5,000 $13.98 22,757 No 4 M Direct
Common Stock Disposition 2021-03-01 5,000 $72.26 17,757 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-03-01 5,000 $0.00 5,000 $13.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-06-02 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.95 to $72.71, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The option vested in 12 equal monthly installments beginning on July 2, 2011.